HIPRA

HIPRA, formally Laboratorios Hipra S.A., is a biotech pharmaceutical company headquartered in Amer, Catalonia, Spain.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

HIPRA, formally Laboratorios Hipra S.A., is a biotech pharmaceutical company headquartered in Amer, Catalonia, Spain. Founded in 19711, it focuses on the development, manufacturing, and commercialization of biological products for animal and human health.

HIPRA has an international presence in 40 countries with its own subsidiaries, 3 research and development centres and 6 production sites located in Europe and America. It also maintains open distribution channels with more than 100 countries. The company operates three main business divisions.

The animal health division, its core historical business, maintains a portfolio of over 100 vaccines with 25 more in development. The human health unit, started in 2020, focuses on COVID-19 vaccines and digestive health products. The biotech services division was introduced in 2025 and operates as a contract development and manufacturing organization (CDMO).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369669003 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “HIPRA” revision 1369669003 · retrieved 2026-10-20 date of foundation (×1) · confidence 0.95 revision URL